GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » 12-1 Month Momentum %

Magellan Health (Magellan Health) 12-1 Month Momentum % : 0.85% (As of May. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Magellan Health 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-05), Magellan Health's 12-1 Month Momentum % is 0.85%.

The industry rank for Magellan Health's 12-1 Month Momentum % or its related term are showing as below:

MGLN's 12-1 Month Momentum % is not ranked
in the Healthcare Plans industry.
Industry Median: -6.07 vs MGLN: 0.85

Competitive Comparison of Magellan Health's 12-1 Month Momentum %

For the Healthcare Plans subindustry, Magellan Health's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magellan Health's 12-1 Month Momentum % Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Magellan Health's 12-1 Month Momentum % falls into.



Magellan Health  (NAS:MGLN) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magellan Health  (NAS:MGLN) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Magellan Health 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Magellan Health's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Magellan Health (Magellan Health) Business Description

Traded in Other Exchanges
N/A
Address
4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.
Executives
Mostafa Kamal officer: CEO, Magellan Rx Management 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West officer: SVP & Controller 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld director 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie director NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen director 4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson director
James E Murray officer: President and COO 500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis officer: Chief Human Resources Officer 55 NOD ROAD AVON CT 06001
Kenneth J Fasola director, officer: Chief Executive Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin officer: Chief Financial Officer 55 NOD ROAD AVON CT 06001

Magellan Health (Magellan Health) Headlines